- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 3.15M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $36.76M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $45.26M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $223.56M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $210.13M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $267.1M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $266.35M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $491.14M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $476.95M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 3.17M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $108.91K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.02M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $2.92 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $2.92 |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $9.24M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $16.91M |